Diagnostic Interval: Experiences among Women with Breast Cancer in Malaysia

Author:

Mamat Wan Hasliza WanORCID,Jarrett Nikki,Lund Susi

Abstract

BACKGROUND: The diagnostic pathway is critical for early breast cancer detection and prognosis improvement. Countries such as the United Kingdom, particularly England, have implemented faster diagnosis standards to ensure that patients receive a definitive diagnosis of cancer or are ruled out within 28 days of referral. However, there is a severe shortage of data on the experiences of breast cancer patients in Malaysia during the diagnostic interval. AIM: This study aimed to explore what happened to the women during the diagnostic phase prior to confirmation of breast cancer. METHODOLOGY: Purposive sampling was applied, and 14 participants were recruited from two government hospitals. The participants took part in in-depth, face-to-face, one-time, and audio-recorded interviews. All the interviews were subsequently transcribed verbatim and analyzed using narrative analysis. RESULTS: The diagnostic interval for the women in this study was 1–3 months from first medical contact till diagnosis. Four themes were identified during the analysis for the diagnostic interval: 1) Women who are suspected of having breast cancer; 2) Women who experience false reassurance; 3) Woman who experience delayed referral; and 4) Women who experience inconclusive investigation results. CONCLUSIONS: This study indicates that early warning signs of breast cancer may prompt doctors to take immediate action. However, unexpected delays may occur as a result of staffing and system issues in the healthcare system. Healthcare professionals should aggressively refer patients with typical symptoms and actively follow-up with patients who present with atypical symptoms in the community. Continuing education for healthcare professionals is necessary to improve diagnostic and referral procedures.

Publisher

Scientific Foundation SPIROSKI

Subject

General Medicine

Reference27 articles.

1. World Health Organization. Breast Cancer. Geneva: World Health Organization; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/breast-cancer [Last accessed on 2021 Jul 10].

2. National Breast Cancer Foundation. Breast Cancer Facts; 2021. Available from: https://www.nationalbreastcancer.org/breast-cancer-facts [Last accessed on 2021 Jul 10].

3. Breast Cancer Now. Facts and Statistics; 2021. Available from: https://www.breastcancernow.org/about-us/media/facts-statistics [Last accessed on 2021 Jul 10].

4. National Cancer Institute. Breast Cancer Risk in American Women; 2019. Available from: http://www.cancer.gov/types/breast/risk-fact-sheet [Last accessed on 2019 Jun 04].

5. Cancer Research UK. Breast Cancer Genes; 2019. Available from: http://www.cancerresearchuk.org/about-cancer/type/breast-cancer/about/risks/breast-cancer-genes [Last accessed on 2019 Jan 10].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3